Guo R - Search Results

1

Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine.

Zuo XC, Zhou YN, Zhang BK, Yang GP, Cheng ZN, Yuan H, Ouyang DS, Liu SK, Barrett JS, Li PJ, Liu Z, Tan HY, Guo R, Zhou LY, Xie YL, Li ZJ, Li J, Wang CJ, Wang JL. Zuo XC, et al. Among authors: guo r. Drug Metab Pharmacokinet. 2013;28(5):398-405. doi: 10.2133/dmpk.dmpk-12-rg-148. Epub 2013 Feb 26. Drug Metab Pharmacokinet. 2013. PMID: 23438946 Free article. Clinical Trial.

2

No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.

Guo X, Chen XP, Cheng ZN, Luo X, Guo R, Chen L, Chen J, Chen B, Peng J, Li YJ. Guo X, et al. Among authors: guo r. Clin Chem Lab Med. 2009;47(1):38-43. doi: 10.1515/CCLM.2009.019. Clin Chem Lab Med. 2009. PMID: 19072027 Clinical Trial.

3

Association of GSTM1 null polymorphism with isosorbide-5-mononitrate cardiovascular response and involvement of CGRP in healthy Chinese male volunteers.

Guo R, Chen L, Li L, Guo X, Sun J, Xiong XM, Cheng ZN, Li YJ, Chen XP. Guo R, et al. Among authors: guo x. Pharmacogenet Genomics. 2011 Mar;21(3):142-51. doi: 10.1097/FPC.0b013e328343ea0a. Pharmacogenet Genomics. 2011. PMID: 21278620 Clinical Trial.

4

NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG₂ hepatoma cell line.

Zuo QP, Liu SK, Li ZJ, Li B, Zhou YL, Guo R, Huang LH. Zuo QP, et al. Among authors: guo r. Eur J Pharmacol. 2011 Dec 15;672(1-3):113-20. doi: 10.1016/j.ejphar.2011.09.187. Epub 2011 Oct 12. Eur J Pharmacol. 2011. PMID: 22008847

5

[Developments in the study of CD40/ CD40L gene and its polymorphism in atherosclerosis].

Wu T, Guo R, Zhang B. Wu T, et al. Among authors: guo r. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Apr;37(4):413-8. doi: 10.3969/j.issn.1672-7347.2012.04.017. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22561578 Review. Chinese.

6

[Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine].

Zuo XC, Yuan H, Zhang BK, Ng CM, Barrett JS, Yang GP, Huang ZJ, Pei Q, Guo R, Zhou YN, Jing NN, Di W. Zuo XC, et al. Among authors: guo r. Yao Xue Xue Bao. 2012 Jul;47(7):941-6. Yao Xue Xue Bao. 2012. PMID: 22993862 Clinical Trial. Chinese.

7

Association of CD40--1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population.

Zhang B, Wu T, Song C, Chen M, Li H, Guo R. Zhang B, et al. Among authors: guo r. Int Immunopharmacol. 2013 Aug;16(4):461-5. doi: 10.1016/j.intimp.2013.04.028. Epub 2013 May 10. Int Immunopharmacol. 2013. PMID: 23669336

8

The CD40/CD40L system: a new therapeutic target for disease.

Zhang B, Wu T, Chen M, Zhou Y, Yi D, Guo R. Zhang B, et al. Among authors: guo r. Immunol Lett. 2013 Jun;153(1-2):58-61. doi: 10.1016/j.imlet.2013.07.005. Epub 2013 Jul 25. Immunol Lett. 2013. PMID: 23892087 Review.

9

Evidence for involvement of the CD40/CD40L system in post-stroke epilepsy.

Zhang B, Chen M, Yang H, Wu T, Song C, Guo R. Zhang B, et al. Among authors: guo r. Neurosci Lett. 2014 May 1;567:6-10. doi: 10.1016/j.neulet.2014.03.003. Epub 2014 Mar 19. Neurosci Lett. 2014. PMID: 24657679

10

The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels.

Yang H, Song Z, Yang GP, Zhang BK, Chen M, Wu T, Guo R. Yang H, et al. Among authors: guo r. PLoS One. 2014 Oct 14;9(10):e109634. doi: 10.1371/journal.pone.0109634. eCollection 2014. PLoS One. 2014. PMID: 25313998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,918 results

Search Page

Filters